Yurista, S. R., Silljé, H. H. W., van Goor, H., Hillebrands, J., Heerspink, H. J. L., de Menezes Montenegro, L., . . . Westenbrink, B. D. (2020). Effects of Sodium–Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction. Cardiovasc Drugs Ther.
Chicago Style aipamenaYurista, Salva R., Herman H. W. Silljé, Harry van Goor, Jan-Luuk Hillebrands, Hiddo J. L. Heerspink, Luiz de Menezes Montenegro, Silke U. Oberdorf-Maass, Rudolf A. de Boer, and B. Daan Westenbrink. "Effects of Sodium–Glucose Co-transporter 2 Inhibition With Empaglifozin On Renal Structure and Function in Non-diabetic Rats With Left Ventricular Dysfunction After Myocardial Infarction." Cardiovasc Drugs Ther 2020.
MLA aipamenaYurista, Salva R., et al. "Effects of Sodium–Glucose Co-transporter 2 Inhibition With Empaglifozin On Renal Structure and Function in Non-diabetic Rats With Left Ventricular Dysfunction After Myocardial Infarction." Cardiovasc Drugs Ther 2020.